Religious young women are less knowledgeable about a vaccine that guards against several different types of cancer, suggests a new study from Utah.... Read More
Studying Cancer Disparities in Vulnerable Populations
The Kepka group is engaged in population science research that addresses health disparities related to cancer risk in vulnerable populations. Our goals are to drive quality improvement and increase access to primary health care services for cancer prevention and control among minority and underserved populations.
Learn more about the Kepka lab’s research >>
News & Blog
Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations
Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).... Read More
Thousands of lives could be saved by a simple vaccination to protect against Human Papillomavirus (HPV). Yet only 51% of teens receive the vaccine each year. Every year more than four thousand people die from cancers related to HPV. It's upsetting, it's really upsetting,” says Deanna Kepka, PhD, MPH, a population scientist at Huntsman Cancer Institute (HCI). “If you ask any cancer survivor whether they would have taken an opportunity to get a vaccine that prevented their cancer, they would say yes.”... Read More